SLC6A3 and Parkinson disease: There is a decline in DAT binding that defines a threshold for early Parkinsonism (Guttman et al. 1997) making it possible to follow disease progression in PD patients (Nurmi et al. 2000; Marek et al. 2001; Winogrodzka et al. 2001).